3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Breast Neoplasms
14
Neoplasms
12
Myelodysplastic Syndromes
12
Prostatic Neoplasms
10
Multiple Myeloma
8
Lung Neoplasms
7
Stomach Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Recurrence
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumor
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Solid Tumor
3
Small Cell Lung Carcinoma
3
Pain
3
Mucositis
3
Lymphoma, T-Cell, Peripheral
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Skin Neoplasms
2
Interventions
Adalimumab
13
Etanercept
8
Methotrexate
7
Rituximab
6
Abatacept
6
tocilizumab
5
golimumab
5
tofacitinib
4
olokizumab
4
Certolizumab Pegol
4
Tumor Necrosis Factor Inhibitors
3
Infliximab
3
Saline Solution
2
Antirheumatic Agents
2
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
baricitinib
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Sulfasalazine
1
Sodium Chloride
1
Radioimmunodetection
1
RC-18
1
Pharmaceutical Preparations
1
Lysine Acetyltransferase 5
1
Leflunomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Arthritis, Rheumatoid
×
Injections
×
Clear all
NCT05090124
2025-01-14
REALISE
NHS Greater Glasgow and Clyde
Phase NA
Completed
46 enrolled